Generation of drug-resistant tumors using intermittent dosing of tyrosine kinase inhibitors in mouse

Cold Spring Harbor Protocols

Volumn 2014, Issue 2, 2014, Pages 178-181

  Pirazzoli, Valentina ^b   Politi, Katerina ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; LUNG NEOPLASMS; MICE; PROTEIN KINASE INHIBITORS;

EID: 84893324828     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.prot077842     Document Type: Article

References (2)

1. Olive KP, Politi K. 2014. Translational therapeutics in genetically engineered mouse models of cancer. Cold Spring Harb Protoc doi: 10.1101/pdb.top069997.
2. Politi K, Fan PD, Shen R, Zakowski M, Varmus H. 2010. Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma. Dis Model Mech 3: 111-119.